Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
8
×
boston blog main
clinical trials
8
×
investing
8
×
life sciences
national blog main
boston top stories
deals
fda
national top stories
startups
san francisco blog main
medical device
venture capital
drug delivery
eli lilly
new york blog main
perceptive advisors
roche
san francisco top stories
software
480 biomedical
akouos
allosteric
antisense oligonucleotide
arrowmark partners
arsenal medical
ascension ventures
astellas pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
avapritinib
benzodiazepines
beta bionics
bigfoot biomedical
biofourmis
biogen
biovotion
What
medicines
million
therapeutics
developing
new
treat
closed
company
digital
drug
fda
ipo
patients
raised
raises
startup
tests
turn
address
adds
affects
ago
aiming
aims
allosteric
americans
analytics
approval
approved
backed
beta
biofourmis
bionics
biotech
blood
blueprint
cancer
candidate
cause
ceo
Language
unset
Current search:
investing
×
boston
×
" clinical trials "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence